Directory › Rentschler Biopharma

Rentschler Biopharma — Milford

Milford, Massachusetts, United States · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Rentschler Biopharma
Name(s) in FDA data
Rentschler Biopharma Inc.
FEI number(s)
3003282293 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Milford, Massachusetts, United States 01757
Records matched
4 FDA inspections
Most recent FDA inspection in dataset
17 Jan 2025 — VAI

Capabilities (from the company's website)

  • Formulation & process development
    …-approved biopharmaceuticals in 2023. Our services We offer full-service solutions for bioprocess development and manufacturing of high-quality biopharmaceuticals Fueled by 50 years of experience in…

Taken from a company-level page; the company does not publish a separate page for this site, so tags may describe the wider organisation. Source: https://www.rentschler-biopharma.com/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 17 Jan 2025
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3003282293, inspection ID 1259307)

  2. 13 Dec 2019
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Biologics. Project area(s): Blood and Blood Products.

    Source: FDA Data Dashboard – Inspections (FEI 3003282293, inspection ID 1116307)

  3. 26 Mar 2018
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Biologics. Project area(s): Blood and Blood Products.

    Source: FDA Data Dashboard – Inspections (FEI 3003282293, inspection ID 1046134)

  4. 23 Feb 2016
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Biologics. Project area(s): Blood and Blood Products.

    Source: FDA Data Dashboard – Inspections (FEI 3003282293, inspection ID 961189)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.